NOW Thai HAART Study

Rajavithi Hospital

Status: Completed

Conditions: AIDS; Neurological Complications; HIV

Treatments: Drug: Highly Active Antiretroviral Treatment (combination of :NRTI, NNRTI,or PI)

Study type: Observational

Funder types: Other

Identifiers

NCT00367731

RVH_CER_003

Details and patient eligibility

About

After Initiation of HAART in peoples who living with HIV/AIDS in Thailand by the year 2000, rapidly expanded HAART access of national project has been promoted in 2004. Free ARVs (For CD4<200cell/cu.mm. or in symptomatic HIV with CD4<250 cell/cu.mm. )and CD4 monitoring has been available. The first-line regimen is d4T+3TC+NVP in mainly the first time (Naive) patients. CD4 response ), rate of opportunistic infection, and neurological outcomes were measured. Rate of ARV change, adverse events,treatment failure, TB co-infection rate, percent changing to EFV-based regimen or PI-based regimen were recorded.

Any Adverse Events including, Sever rash, Severe Hepatitis, Lipid abnormalities, Severe Anemia and Other, common AEs will be analysed.

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HIV/AIDS patients.
• Age >15 years.
• informed consent

Exclusion criteria

• Not informed consent